Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.
Lancet Neurol
; 17(12): 1043-1052, 2018 12.
Article
in En
| MEDLINE
| ID: mdl-30337273
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Insulin-Like Growth Factor I
/
Muscular Atrophy
/
Treatment Outcome
/
Bulbo-Spinal Atrophy, X-Linked
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Neurol
Year:
2018
Document type:
Article